What Results Can Patients Expect
Our goal when developing obesity medicines is to help patients reach a place that feels healthy, comfortable and maintainable, a spokesperson for Lilly told The Post
While Retatrutide has generated significant excitement in obesity medicine due to encouraging clinical trial results, it remains an investigational medication that is currently in Phase 3 clinical trials and has not yet received FDA approval
The FDA Boxed Warning is based on animal studies in rodents, where thyroid C-cell tumors developed, but the relevance to humans remains uncertain
Questo facilita il loro ingresso nelle mitocondri, dove vengono metabolizzati per produrre energia tramite la beta-ossidazione
GLP-1 medications require consistent adherence, may require lifestyle modifications, and come with a titration period during which side effects are common